Tag: Adaptimmune Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Adaptimmune Therapeutics

Adaptimmune Therapeutics (NASDAQ:ADAP) Cut to Sell at BidaskClub

Added to Collection on: 2018-11-26 14:45:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Leerink Swann Lowers Adaptimmune Therapeutics (ADAP) to Market Perform

Added to Collection on: 2019-05-10 01:05:38

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Raymond James Trims Adaptimmune Therapeutics (ADAP) Target Price to $6.00

Added to Collection on: 2019-05-09 23:48:02

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (ADAP) Lowered to Market Perform at Leerink Swann

Added to Collection on: 2019-05-15 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (ADAP) Price Target Cut to $6.00 by Analysts at Raymond James

Added to Collection on: 2019-05-15 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (NASDAQ:ADAP) Rating Lowered to Sell at BidaskClub

Added to Collection on: 2019-05-16 19:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (NASDAQ:ADAP) PT Lowered to $6.00

Added to Collection on: 2019-05-16 23:33:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (NASDAQ:ADAP) Stock Rating Lowered by BidaskClub

Added to Collection on: 2019-08-17 06:07:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (NASDAQ:ADAP) Upgraded at BidaskClub

Added to Collection on: 2020-12-25 06:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Adaptimmune Therapeutics (NASDAQ:ADAP) Now Covered by Analysts at StockNews.com

Added to Collection on: 2025-04-06 14:55:28

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo